Related Experiment Videos
Diffuse pulmonary arteriovenous malformations: characteristics and prognosis.
M E Faughnan1, Y W Lui, J A Wirth
1Division of Respiratory Medicine, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Chest
|January 13, 2000
Summary
Patients with diffuse pulmonary arteriovenous malformations (AVMs) face severe hypoxia and a high risk of neurologic complications. While transcatheter embolotherapy offers limited oxygenation improvement, it may reduce neurologic risks, allowing productive lives.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Neurology
Background:
- Diffuse pulmonary arteriovenous malformations (AVMs) are rare vascular anomalies.
- Patients often present with severe hypoxemia and are at significant risk for systemic complications.
Purpose of the Study:
- To investigate the clinical features and long-term prognosis of patients diagnosed with diffuse pulmonary AVMs.
- To evaluate the effectiveness of transcatheter embolotherapy and other interventions.
Main Methods:
- Retrospective chart review of 16 patients with diffuse pulmonary AVMs across three major hospitals.
- Inclusion of up-to-date follow-up information for all living patients.
Main Results:
- All patients experienced severe hypoxia; 70% had neurologic complications (stroke, brain abscess) by diagnosis.
- Mean follow-up was 6 years, with 3 deaths (1 perioperative transplant) and 2 new neurologic events.
- Transcatheter embolotherapy showed limited oxygenation improvement, but pulmonary flow redistribution offered a small significant benefit.
Conclusions:
- Diffuse pulmonary AVMs confer a high risk of neurologic complications and severe hypoxia.
- Transcatheter embolotherapy may reduce neurologic risks but does not significantly improve oxygenation.
- Antibiotic prophylaxis is advised for bacteremic procedures; lung transplantation is not recommended due to unpredictable survival and perioperative risks.